Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Aida Habtezion

Board of Governors

Chief Medical Officer and Head of Worldwide Medical & Safety, Pfizer Inc

As Chief Medical Officer of Pfizer, Aida Habtezion leads Pfizer's Worldwide Medical & Safety organization responsible for ensuring that patients, physicians, and regulatory agencies are provided with information on the safe and appropriate use of Pfizer medications.

Prior to joining Pfizer, Dr. Habtezion was a practicing physician and scientist at Stanford University's School of Medicine, Gastroenterology, and Digestive Health Clinic. She led an NIH-funded translational lab focused on understanding immune mechanisms and identifying potential immune-based therapeutic targets for pancreatitis and inflammatory bowel disease. While working in the lab, she served as a tenured Associate Professor of Medicine specializing in gastroenterology and hepatology, an Associate Dean for Academic Affairs, a faculty member in Stanford's Immunology Ph.D. program, Neuroscience Institute, Cancer Institute, Maternal & Child Health Research Institute, and faculty fellow at Stanford's ChEM-H (Chemistry, Engineering & Medicine for Human Health) at Stanford University School of Medicine. Dr. Habtezion is a tenured professor and currently on a leave of absence from Stanford.

Dr. Habtezion is the recipient of the Robert Wood Johnson Harold Amos Medical Faculty Development Award, Gastroenterology & Hepatology Teaching Award, the Immunology Faculty Mentor of the Year, Synergy Award from the Kenneth Rainin Foundation for her research in Inflammatory Bowel Disease and was named the Allen Distinguished Investigator. She was elected into the American Society for Clinical Investigation, Association of American Physicians, and the American Pancreas Association (APA) Council. Currently, she is the APA President-elect.

Dr. Habtezion obtained her Bachelor of Science in Chemistry from the University of Alberta and Master of Science in Nutritional Sciences at the University of Guelph. She completed her medical degree from McMaster University. Dr. Habtezion completed her Internal Medicine residency from the University of Western Ontario and Gastroenterology & Hepatology clinical fellowship from the University of Toronto in Canada. Following her clinical fellowship training, she obtained postdoctoral research training in Immunology at Stanford University.

Dr. Habtezion was born in Eritrea and has lived on three continents and four countries. She enjoys traveling, music, and learning about different cultures.